Jean Berthelet

1.4k total citations · 1 hit paper
19 papers, 845 citations indexed

About

Jean Berthelet is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Jean Berthelet has authored 19 papers receiving a total of 845 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 11 papers in Cancer Research and 6 papers in Oncology. Recurrent topics in Jean Berthelet's work include Cell death mechanisms and regulation (10 papers), Ubiquitin and proteasome pathways (6 papers) and NF-κB Signaling Pathways (6 papers). Jean Berthelet is often cited by papers focused on Cell death mechanisms and regulation (10 papers), Ubiquitin and proteasome pathways (6 papers) and NF-κB Signaling Pathways (6 papers). Jean Berthelet collaborates with scholars based in France, Australia and Germany. Jean Berthelet's co-authors include Laurence Dubrez, Delphine Mérino, Shalin H. Naik, Verena C. Wimmer, Kelly L. Rogers, Xiao Tan, Marie-Liesse Asselin-Labat, Quan Nguyen, Arthur Marivin and Krishnaraj Rajalingam and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Nature reviews. Cancer.

In The Last Decade

Jean Berthelet

19 papers receiving 836 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Spatial omics and multiplexed imaging to explore cancer biology

2021 341 citations Marie-Liesse Asselin-Labat, Quan Nguyen et al. Nature Methods profile →

Peers

Countries citing papers authored by Jean Berthelet

Since Specialization

Citations

This map shows the geographic impact of Jean Berthelet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jean Berthelet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jean Berthelet more than expected).

Fields of papers citing papers by Jean Berthelet

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jean Berthelet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jean Berthelet. The network helps show where Jean Berthelet may publish in the future.

Co-authorship network of co-authors of Jean Berthelet

This figure shows the co-authorship network connecting the top 25 collaborators of Jean Berthelet. A scholar is included among the top collaborators of Jean Berthelet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jean Berthelet. Jean Berthelet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	Experimental and spontaneous metastasis assays can result in divergence in clonal architecture 2023 ·Communications Biology ·Antonin Serrano, Tom Weber, Jean Berthelet, Farrah El-Saafin, (unknown), Emmanuelle Charafe‐Jauffret, Christophe Ginestier, John M. Mariadason, Samantha R. Oakes, Kara L. Britt, Shalin H. Naik, Delphine Mérino	2
2	Single‐cell RNA sequencing captures patient‐level heterogeneity and associated molecular phenotypes in breast cancer pleural effusions 2023 ·Clinical and Translational Medicine ·(unknown), Jean Berthelet, Stefano Mangiola, (unknown), Robin L. Anderson, Bhupinder Pal, Belinda Yeo, Anthony T. Papenfuss, Delphine Mérino, Melissa J. Davis	5
3	Computational Screening of Anti-Cancer Drugs Identifies a New BRCA Independent Gene Expression Signature to Predict Breast Cancer Sensitivity to Cisplatin 2022 ·Cancers ·Jean Berthelet, Momeneh Foroutan, Dharmesh D. Bhuva, (unknown), Farrah El-Saafin, Joseph Cursons, Antonin Serrano, (unknown), Elgene Lim, Emmanuelle Charafe‐Jauffret, Christophe Ginestier, Matthias Ernst, Frédéric Hollande, Robin L. Anderson, Bhupinder Pal, Belinda Yeo, Melissa J. Davis, Delphine Mérino	1
4	cIAP1/TRAF2 interplay promotes tumor growth through the activation of STAT3 2022 ·Oncogene ·(unknown), (unknown), Jean Berthelet, Sébastien Causse, (unknown), (unknown), (unknown), Cindy Racoeur, Catherine Paul, Carmen Garrido, Laurence Dubrez	6
5	Mastering the use of cellular barcoding to explore cancer heterogeneity 2022 ·Nature reviews. Cancer ·Antonin Serrano, Jean Berthelet, Shalin H. Naik, Delphine Mérino	31
6	Spatial omics and multiplexed imaging to explore cancer biology breakdown → 2021 ·Nature Methods ·(unknown), Marie-Liesse Asselin-Labat, Quan Nguyen, Jean Berthelet, Xiao Tan, Verena C. Wimmer, Delphine Mérino, Kelly L. Rogers, Shalin H. Naik	341
7	Targeting triple-negative breast cancers with the Smac-mimetic birinapant 2020 ·Cell Death and Differentiation ·Najoua Lalaoui, Delphine Mérino, Göknur Giner, François Vaillant, Diep Chau, Lin Liu, Tobias Kratina, Bhupinder Pal, James R. Whittle, Nima Etemadi, Jean Berthelet, Julius Gräsel, Cathrine Hall, Matthew E. Ritchie, Matthias Ernst, Gordon K. Smyth, David L. Vaux, Jane E. Visvader, Geoffrey J. Lindeman, John Silke	36
8	Proteogenomics analysis unveils a TFG-RET gene fusion and druggable targets in papillary thyroid carcinomas 2020 ·Nature Communications ·(unknown), Jean Berthelet, Emilie Renaud, Sebastian Rosigkeit, Ute Distler, Eric Stawiski, Jing Wang, Zora Modrušan, Marc Fiedler, Mariann Bienz, Stefan Tenzer, Arno Schad, Wilfried Roth, Bernd Thiede, Somasekar Seshagiri, Thomas J. Musholt, Krishnaraj Rajalingam	22
9	E2F1 binds to the peptide-binding groove within the BIR3 domain of cIAP1 and requires cIAP1 for chromatin binding 2018 ·PLoS ONE ·(unknown), Jessy Cartier, (unknown), Nathalie Droin, (unknown), (unknown), Jean Berthelet, Simon Gemble, (unknown), Laurent Maillet, Carmen Garrido, Laurence Dubrez	6
10	HMG-CoA reductase promotes protein prenylation and therefore is indispensible for T-cell survival 2017 ·Cell Death and Disease ·Sonja M. Lacher, Julia Bruttger, (unknown), Jean Berthelet, Krishnaraj Rajalingam, Simone Wörtge, Ari Waisman	37
11	DNA damage and S phase-dependent E2F1 stabilization requires the cIAP1 E3-ubiquitin ligase and is associated with K63-poly-ubiquitination on lysine 161/164 residues 2017 ·Cell Death and Disease ·(unknown), (unknown), Jean Berthelet, (unknown), (unknown), Nathalie Droin, (unknown), Jessy Cartier, Simon Gemble, Guillaume Marcion, (unknown), Romain Boidot, Carmen Garrido, (unknown), Éric Solary, Laurence Dubrez	20
12	Apoptosis inhibitor 5 is an endogenous inhibitor of caspase‐2 2017 ·EMBO Reports ·Gergely Imre, Jean Berthelet, Jan Heering, Sebastian Kehrloesser, (unknown), Byung Il Lee, Bernd Thiede, Volker Dötsch, Krishnaraj Rajalingam	30
13	Symplekin, a polyadenylation factor, prevents MOZ and MLL activity on HOXA9 in hematopoietic cells 2013 ·Biochimica et Biophysica Acta (BBA) - Molecular Cell Research ·Anne Largeot, Jérôme Paggetti, Julien Broséus, Romain Aucagne, Brice Lagrange, (unknown), Jean Berthelet, Ronan Quéré, Géraldine Lucchi, Patrick Ducoroy, Jean Bastié, Laurent Delva	5
14	IAP proteins as targets for drug development in oncology 2013 ·OncoTargets and Therapy ·Laurence Dubrez, Jean Berthelet, (unknown)	94
15	cIAP1 regulates TNF-mediated cdc42 activation and filopodia formation 2013 ·Oncogene ·Arthur Marivin, Jean Berthelet, Jessy Cartier, Catherine Paul, Simon Gemble, Alexandre Morizot, Wilfrid Boireau, Maya Saleh, Jacques Bertoglio, Éric Solary, Laurence Dubrez	20
16	Regulation of Apoptosis by Inhibitors of Apoptosis (IAPs) 2013 ·Cells ·Jean Berthelet, Laurence Dubrez	124
17	Les IAP au cœur de la signalisation NF-κB 2012 ·médecine/sciences ·Jessy Cartier, Arthur Marivin, Jean Berthelet, Laurence Dubrez	6
18	The Inhibitor of Apoptosis (IAPs) in Adaptive Response to Cellular Stress 2012 ·Cells ·Arthur Marivin, Jean Berthelet, Stéphanie Plenchette, Laurence Dubrez	24
19	Cellular Inhibitor of Apoptosis Protein-1 (cIAP1) Can Regulate E2F1 Transcription Factor-mediated Control of Cyclin Transcription 2011 ·Journal of Biological Chemistry ·Jessy Cartier, Jean Berthelet, Arthur Marivin, Simon Gemble, Valérie Edmond, Stéphanie Plenchette, Brice Lagrange, Arlette Hammann, (unknown), Laurent Delva, Béatrice Eymin, Éric Solary, Laurence Dubrez	35

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact